ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Radioconjugate Therapy: The Approval Process And the Market Landscap Suzanne Elvidge
August 22, 2025Radioconjugates?? combine ??targeted ligands?? with radioisotopes, enabling precision cancer therapy and theranostics. The ??$7.5B market by 2033?? demands strict FDA ??safety/CMC data?? for NDA/BLA approval. -
Radioconjugates: Targeting for Precision Suzanne Elvidge
May 06, 2025The development of radioconjugates – targeted molecules designed to carry radionuclides directly to cancerous cells, lowering systemic exposure and increasing the precision of treatment.
Pharma Sources Insight July 2025
